A woman with sickle cell disease said the possibility of lab-grown blood has given her "hope" for the future. The aim of the new research is to help those with ultra-rare blood groups who need regular transfusions.

Scientists have made a significant leap towards mass producing platelets – the part of the blood that forms clots.